Cancer pain: pharmacological management (Part Two).
Ghosn
M
M
Hematology-Oncology Department, Hôtel-Dieu de France Hospital, Beirut, Lebanon.
Gannage
M
M
D000700:Analgesics / Q000627:therapeutic use; D000701:Analgesics, Opioid / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D004361:Drug Tolerance; D006801:Humans; D009019:Morphinans / Q000627:therapeutic use; D009020:Morphine / Q000627:therapeutic use; D009294:Narcotics / Q000627:therapeutic use; D009369:Neoplasms / Q000503:physiopathology*; D009293:Opioid-Related Disorders; D010146:Pain / Q000188:drug therapy* / Q000209:etiology; D010276:Parasympatholytics / Q000627:therapeutic use; D011619:Psychotropic Drugs / Q000627:therapeutic use; D019966:Substance-Related Disorders
D000700:Analgesics; D000701:Analgesics, Opioid; D000894:Anti-Inflammatory Agents, Non-Steroidal; D009019:Morphinans; D009294:Narcotics; D010276:Parasympatholytics; D011619:Psychotropic Drugs; D009020:Morphine